Cite

HARVARD Citation

    Komrokji, R. et al. (2018). Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial. Lancet. 5 (2), pp. e63-e72. [Online]. 
  
Back to record